Clinical Trial Update: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous stem cell transplant followed by donor stem cell transplant in relapsed or refractory lymphoma; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma
• Prolymphocytic Leukemia
• Small Lymphocytic Lymphoma
• T-cell Chronic Lymphocytic Leukemia
• T-cell Prolymphocytic Leukemia

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-12-07